Project

General

Profile

Wiki » History » Version 40

Marta Martins Filipe, 26/05/2026 10:14

1 3 Marta Martins Filipe
h1. _Obstech - Tele-CTG_: Conceção e prototipagem dum serviço de telemedicina em obstetrícia
2 3 Marta Martins Filipe
3 23 Marta Martins Filipe
Unidade Curricular de +Telemedicina e e-Saúde+
4 23 Marta Martins Filipe
Faculdade de Engenharia da Universidade do Porto
5 21 Marta Martins Filipe
6 21 Marta Martins Filipe
*Nome dos autores*:
7 21 Marta Martins Filipe
8 24 Marta Martins Filipe
Inês Vasconcelos - up202314982
9 24 Marta Martins Filipe
Maria Videira - up202510611
10 21 Marta Martins Filipe
Marta Filipe - up20250464
11 21 Marta Martins Filipe
12 10 Marta Martins Filipe
h2. *0. Abstract*
13 4 Marta Martins Filipe
14 10 Marta Martins Filipe
The _Obstech – Tele-CTG_ project aims to conceive and prototype an innovative telemedicine service in the field of obstetrics, focused on remote cardiotocography (CTG) monitoring during pregnancy. Cardiotocography is an essential clinical exam that simultaneously records fetal heart rate and uterine activity, traditionally performed in hospital settings.
15 6 Marta Martins Filipe
16 10 Marta Martins Filipe
This project proposes a hybrid model composed of a portable signal acquisition device and an integrated digital platform with two distinct interfaces: one designed for the pregnant woman (patient-facing) and another for healthcare professionals (clinical-facing). The approach is centered on user interviews and functional mockup development to validate the system's utility and feasibility.
17 7 Marta Martins Filipe
18 10 Marta Martins Filipe
The solution addresses a clear gap in the current market, where existing solutions are either highly reliable but hospital-bound, or accessible but lacking clinical integration and intelligent data analysis. Obstech bridges these two extremes by combining clinical-grade CTG monitoring with a patient-centered digital experience.
19 2 Marta Martins Filipe
20 8 Marta Martins Filipe
21 10 Marta Martins Filipe
*Keywords:* Telemedicine, Obstetrics, Cardiotocography, Remote Monitoring, eHealth, Prototyping
22 1 Marta Martins Filipe
23 10 Marta Martins Filipe
h2. *1. Introduction*
24 1 Marta Martins Filipe
25 10 Marta Martins Filipe
h3. *1.1 What is _Obstech – Tele-CTG_?*
26 1 Marta Martins Filipe
27 10 Marta Martins Filipe
_Obstech – Tele-CTG_ is a telemedicine service designed for remote fetal monitoring through cardiotocography (CTG) in home environments. It consists of a portable or wearable device that captures fetal heart rate and uterine activity signals, combined with a digital platform that transmits and displays this data securely to healthcare providers.
28 1 Marta Martins Filipe
29 10 Marta Martins Filipe
The system operates on a hybrid model: the pregnant woman uses the device at home while her clinical data is continuously available to her medical team through a dedicated professional interface. This eliminates the need for frequent hospital visits while maintaining the clinical quality and continuity of fetal monitoring.
30 1 Marta Martins Filipe
31 36 Inês Vasconcelos
Rather than being only a device or only a mobile application, Obstech is conceived as an integrated telemedicine service that connects home-based fetal monitoring with clinical follow-up, combining signal acquisition, patient engagement and professional decision support.
32 1 Marta Martins Filipe
33 10 Marta Martins Filipe
h3. *1.2 The Concept of Remote CTG Monitoring*
34 1 Marta Martins Filipe
35 10 Marta Martins Filipe
Cardiotocography CTG is the simultaneous recording of the fetal heart rate (FHR) and uterine contractions. It is a standard clinical tool used to assess fetal well-being during pregnancy and labor. In its traditional form, CTG requires the pregnant woman to visit a hospital or clinic, where sensors are placed on the abdomen and connected to a monitor.
36 1 Marta Martins Filipe
37 10 Marta Martins Filipe
Remote CTG monitoring refers to the use of portable or wearable sensors to perform CTG outside the clinical setting, typically at home, with data transmitted electronically to healthcare providers. This approach enables continuous or on-demand monitoring, reducing the burden on hospital services and improving access for patients in remote or underserved areas.
38 10 Marta Martins Filipe
39 37 Inês Vasconcelos
In this context, remote CTG monitoring represents a relevant application of telemedicine, as it enables clinical data to be collected outside the hospital while remaining accessible to healthcare professionals. This supports a more continuous, accessible and patient-centered model of pregnancy follow-up.
40 10 Marta Martins Filipe
41 10 Marta Martins Filipe
h3. *1.3 Project Motivation and Objectives*
42 10 Marta Martins Filipe
43 10 Marta Martins Filipe
The motivation for this project stems from the clear limitations of current CTG monitoring practice:
44 10 Marta Martins Filipe
* Frequent and inconvenient hospital visits for routine monitoring;
45 10 Marta Martins Filipe
* Episodic rather than continuous fetal surveillance;
46 10 Marta Martins Filipe
* Overloaded obstetrics departments;
47 10 Marta Martins Filipe
* Limited autonomy for the pregnant woman;
48 10 Marta Martins Filipe
* Poor access for patients in rural or geographically isolated areas.
49 10 Marta Martins Filipe
50 38 Inês Vasconcelos
These limitations create the need for a hybrid solution capable of reducing unnecessary hospital visits while preserving clinical supervision and data quality.
51 38 Inês Vasconcelos
52 11 Marta Martins Filipe
The main objectives of _Obstech – Tele-CTG_ are:
53 10 Marta Martins Filipe
* Develop a remote CTG monitoring solution usable in a home environment;
54 10 Marta Martins Filipe
* Review the state of the art and identify gaps in existing solutions;
55 10 Marta Martins Filipe
* Contact relevant stakeholders (pregnant women, obstetricians, nurses) for requirements gathering;
56 10 Marta Martins Filipe
* Design functional mockups of both the patient and clinical interfaces;
57 1 Marta Martins Filipe
* Validate the proposed system's utility, usability, and clinical viability.
58 11 Marta Martins Filipe
59 11 Marta Martins Filipe
h2. *2. Market Assessment Study*
60 11 Marta Martins Filipe
61 11 Marta Martins Filipe
h3. *2.1 Review of Existing Solutions*
62 11 Marta Martins Filipe
63 39 Inês Vasconcelos
A review of existing fetal and maternal monitoring solutions was conducted in order to understand the current technological landscape and identify opportunities for differentiation. The analysed solutions included hospital-based CTG systems, portable fetal monitoring devices, wearable technologies and remote monitoring platforms.
64 1 Marta Martins Filipe
65 39 Inês Vasconcelos
The comparison was based on five criteria considered relevant for the Obstech concept: home use capability, full CTG measurement, clinical interface, patient interface and automatic data analysis. These criteria were selected because they represent the main dimensions required for a complete telemedicine solution in obstetrics: accessibility, clinical value, professional integration, patient-centered design and decision-support potential.
66 39 Inês Vasconcelos
67 1 Marta Martins Filipe
!Tabela_1.png(300)!
68 39 Inês Vasconcelos
69 39 Inês Vasconcelos
The comparative analysis shows that existing solutions tend to be divided into two main groups. Hospital-centered systems, such as Avalon CL, Sonicaid Team3 and OBIX, provide strong clinical reliability and professional integration, but are mainly designed for use in clinical environments. In contrast, home-based or portable solutions, such as HeraBEAT, PregnaBit Pro, Sense4Baby, iCTG, INVU and PreTel Juno, improve accessibility but often present limitations regarding full CTG acquisition, patient interface design, intelligent analysis or integration with clinical workflows.
70 39 Inês Vasconcelos
71 39 Inês Vasconcelos
This analysis confirms that there is still space for a hybrid solution capable of combining home accessibility with clinical robustness and a meaningful patient-facing experience.
72 16 Marta Martins Filipe
73 16 Marta Martins Filipe
h3. *2.2 Analysis of Available Apps*
74 16 Marta Martins Filipe
75 16 Marta Martins Filipe
Beyond dedicated hardware systems, several mobile applications exist for pregnancy monitoring. These can be broadly grouped into three categories:
76 16 Marta Martins Filipe
* Consumer wellness apps (e.g., baby heartbeat apps): These use the smartphone microphone to detect fetal sounds. They lack clinical accuracy and are not validated for medical use.
77 16 Marta Martins Filipe
* Companion apps for medical devices: Applications paired with CTG devices (e.g., HeraBEAT app, PregnaBit app) that display data from dedicated sensors. These have better accuracy but typically offer limited clinical integration and a basic user experience.
78 16 Marta Martins Filipe
* Hospital platform apps: Web-based or mobile interfaces for clinical staff to access patient monitoring data remotely (e.g., OBIX, Sonicaid). These are clinically robust but are not designed for patient use.
79 16 Marta Martins Filipe
80 16 Marta Martins Filipe
A key finding across all app categories is the consistent absence of a well-designed, patient-centered interface that makes clinical data meaningful and accessible to the pregnant woman without requiring medical expertise.
81 17 Marta Martins Filipe
82 17 Marta Martins Filipe
h3. *2.2 Analysis of Available Apps*
83 17 Marta Martins Filipe
84 17 Marta Martins Filipe
The market analysis reveals a consistent pattern: existing solutions cluster at opposite ends of a spectrum. Clinical systems offer high reliability but require hospital attendance; home devices offer convenience but lack clinical depth and integration.
85 17 Marta Martins Filipe
86 18 Marta Martins Filipe
The identified gaps that _Obstech_ aims to address are:
87 17 Marta Martins Filipe
* No solution combines full CTG monitoring (FHR + uterine activity) in the home setting with a strong clinical platform;
88 17 Marta Martins Filipe
* Patient-facing interfaces are universally underdeveloped — data is displayed without meaningful context for the pregnant woman;
89 17 Marta Martins Filipe
* Automatic analysis and intelligent alerting is either absent or limited in home-use solutions;
90 17 Marta Martins Filipe
* No solution offers a true hybrid model with continuous bidirectional communication between the patient and the clinical team;
91 17 Marta Martins Filipe
* Digital pregnancy records (a unified 'digital pregnancy booklet') are absent from all reviewed solutions.
92 17 Marta Martins Filipe
93 1 Marta Martins Filipe
These gaps define the innovation space for Obstech and directly inform its differentiating features.
94 18 Marta Martins Filipe
95 18 Marta Martins Filipe
h2. *3. Structure*
96 18 Marta Martins Filipe
97 18 Marta Martins Filipe
h3. *3.1 Requirements Gathering*
98 18 Marta Martins Filipe
99 18 Marta Martins Filipe
Requirements for the Obstech system were gathered through a combination of literature review, analysis of existing solutions, and direct contact with end users and healthcare professionals. The requirements gathering process followed an iterative approach, with initial requirements refined based on stakeholder feedback.
100 18 Marta Martins Filipe
101 18 Marta Martins Filipe
Requirements were classified into functional requirements (what the system must do) and non-functional requirements (how the system must perform), and further divided by interface: patient-facing and clinician-facing.
102 18 Marta Martins Filipe
103 18 Marta Martins Filipe
*Key functional requirements identified*:
104 18 Marta Martins Filipe
* Real-time transmission of CTG data (FHR + uterine activity) from home to clinical platform;
105 18 Marta Martins Filipe
* Patient interface: simplified CTG summaries, digital pregnancy booklet, gestational timeline, exam history;
106 18 Marta Martins Filipe
* Clinical interface: full CTG traces, structured patient history, report generation, multi-patient dashboard, alert system;
107 18 Marta Martins Filipe
* Secure and encrypted data storage and transmission (GDPR compliant);
108 18 Marta Martins Filipe
* Interoperability with existing hospital systems (HL7/FHIR standards).
109 18 Marta Martins Filipe
110 18 Marta Martins Filipe
h3. *3.2 Interviews and Iterations*
111 18 Marta Martins Filipe
112 31 Inês Vasconcelos
As Obstech is a user-centered telemedicine solution, stakeholder involvement was considered essential during the conception and prototyping phase. The main purpose of the interview process was to validate the relevance of the problem, identify practical needs from both patient and clinical perspectives, and refine the functional requirements of the proposed system.
113 31 Inês Vasconcelos
114 31 Inês Vasconcelos
A qualitative exploratory approach was adopted, based on semi-structured interviews with two main stakeholder groups: pregnant women or recent mothers, representing the patient perspective, and healthcare professionals involved in pregnancy monitoring, representing the clinical perspective. This method was selected because it allows participants to freely describe their experiences, concerns and expectations, while still ensuring that key topics are addressed consistently across interviews.
115 31 Inês Vasconcelos
116 31 Inês Vasconcelos
The interviews focused on five main dimensions: current experience with CTG monitoring, perceived difficulties associated with hospital-based monitoring, willingness to use a remote CTG solution, expected functionalities in a patient-facing application, and clinical requirements for a professional monitoring platform. Questions were adapted according to the participant profile, with patients being asked mainly about usability, reassurance and communication, while healthcare professionals were asked about clinical workflow, signal reliability, alerts, data interpretation and patient safety.
117 31 Inês Vasconcelos
118 31 Inês Vasconcelos
All quotes presented in this section are anonymized and translated into English where necessary, preserving the meaning of the original statements. The quotes are representative excerpts from the stakeholder feedback collected during the exploratory validation process.
119 31 Inês Vasconcelos
120 31 Inês Vasconcelos
From the patient perspective, the feedback confirmed that CTG monitoring is generally perceived as clinically important, but also associated with inconvenience, anxiety and dependency on hospital availability. Participants valued the possibility of performing monitoring at home, particularly if the system remained connected to healthcare professionals and did not place the responsibility of clinical interpretation on the pregnant woman. A recurring concern was that medical data should be presented in a simple and reassuring way, avoiding technical terminology that could generate unnecessary anxiety.
121 31 Inês Vasconcelos
122 31 Inês Vasconcelos
One participant described this need as follows:
123 31 Inês Vasconcelos
124 31 Inês Vasconcelos
“When I do an exam, I do not necessarily need to understand every medical detail. What I really want to know is whether everything seems normal and whether my doctor has access to the result.”
125 31 Inês Vasconcelos
126 31 Inês Vasconcelos
Another participant emphasized the burden of repeated hospital visits:
127 31 Inês Vasconcelos
128 31 Inês Vasconcelos
“Near the end of pregnancy, going to the hospital several times can become tiring and stressful. If part of that monitoring could be done safely at home, it would make the process much easier.”
129 31 Inês Vasconcelos
130 31 Inês Vasconcelos
These findings directly influenced the design of the patient-facing application. As a result, the app was designed to prioritize a simple dashboard, plain-language CTG summaries, pregnancy progression, exam history, notifications and a digital pregnancy booklet. The patient interface deliberately avoids displaying complex raw clinical traces as the main element. Instead, it presents summarized and contextualized information, while ensuring that complete data remains available to the healthcare team.
131 31 Inês Vasconcelos
132 31 Inês Vasconcelos
From the clinical perspective, healthcare professionals recognized the potential of remote CTG monitoring to improve accessibility and reduce unnecessary hospital visits, especially for pregnant women requiring regular follow-up or living far from healthcare facilities. However, they also stressed that remote monitoring should not compromise clinical rigor. The professional interface must therefore provide complete CTG traces, signal quality indicators, patient history, previous monitoring sessions and clear alert prioritization.
133 31 Inês Vasconcelos
134 31 Inês Vasconcelos
One healthcare professional highlighted this distinction:
135 31 Inês Vasconcelos
136 31 Inês Vasconcelos
“For the patient, the information should be simple. For the clinician, it cannot be simplified too much. We need access to the complete CTG trace, the clinical context and the evolution over time.”
137 31 Inês Vasconcelos
138 31 Inês Vasconcelos
Another important concern was related to signal quality and false alarms:
139 31 Inês Vasconcelos
140 31 Inês Vasconcelos
“In remote monitoring, signal quality is critical. Before generating an alert, the system must be able to distinguish between a real clinical concern and a poor-quality recording.”
141 31 Inês Vasconcelos
142 31 Inês Vasconcelos
This feedback reinforced the need to include signal quality validation as a core system functionality. Consequently, the Obstech workflow was refined to include technical validation before clinical interpretation. Poor signal acquisition, incomplete transmission or device connection problems are treated as technical alerts, while abnormal fetal heart rate patterns or concerning uterine activity are treated as clinical alerts.
143 31 Inês Vasconcelos
144 31 Inês Vasconcelos
Healthcare professionals also emphasized that automatic analysis should support, but never replace, clinical decision-making. Therefore, the system was positioned as a clinical decision-support tool rather than an autonomous diagnostic system.
145 31 Inês Vasconcelos
146 31 Inês Vasconcelos
This was summarized by one professional as follows:
147 31 Inês Vasconcelos
148 31 Inês Vasconcelos
“The platform can help us prioritize cases and detect patterns faster, but the final interpretation must always remain with the healthcare professional.”
149 31 Inês Vasconcelos
150 31 Inês Vasconcelos
The interviews also contributed to the refinement of the clinical platform. Initially, the concept was mainly focused on CTG visualization and report generation. After the feedback, additional features were reinforced, including multi-patient monitoring, structured patient history, alert categorization, clinical notes, patient contact and trend analysis across multiple CTG sessions. These elements were considered important to integrate the solution into a realistic clinical workflow.
151 31 Inês Vasconcelos
152 31 Inês Vasconcelos
The concept of the digital pregnancy booklet was also validated during the interviews. Patients considered it useful to have pregnancy-related information centralized in a single place, including CTG summaries, appointments, clinical notes and pregnancy evolution. This feature was therefore maintained as one of the differentiating elements of Obstech, since many existing solutions focus mainly on monitoring data and do not provide a complete patient-centered pregnancy record.
153 31 Inês Vasconcelos
154 31 Inês Vasconcelos
Based on the interview feedback, the mockups were iteratively refined. The main changes included simplifying the language used in the patient app, improving the visibility of the latest CTG result, adding clearer navigation to the pregnancy booklet, reinforcing notifications and messages, and expanding the clinical dashboard to include alert status, patient history and monitoring trends. These iterations helped align the prototype with the expectations of both end users and healthcare professionals.
155 31 Inês Vasconcelos
156 31 Inês Vasconcelos
The main requirements refined through the interview process were:
157 31 Inês Vasconcelos
158 33 Inês Vasconcelos
* The patient interface must present information in simple, reassuring and non-technical language;
159 33 Inês Vasconcelos
* The clinical platform must provide access to complete CTG traces and detailed patient history;
160 33 Inês Vasconcelos
* Signal quality must be validated before data interpretation;
161 33 Inês Vasconcelos
* Alerts must be separated into technical alerts and clinical alerts;
162 33 Inês Vasconcelos
* The system must support secure communication between the pregnant woman and the healthcare team;
163 33 Inês Vasconcelos
* The digital pregnancy booklet should centralize pregnancy evolution, exams and relevant clinical information;
164 33 Inês Vasconcelos
* Automatic analysis should support clinical prioritization without replacing professional judgment;
165 33 Inês Vasconcelos
* The solution must be intuitive enough for home use while maintaining clinical reliability.
166 31 Inês Vasconcelos
167 31 Inês Vasconcelos
Overall, the interview process confirmed the relevance of the Obstech value proposition. The findings showed that the proposed solution addresses not only a logistical problem, related to hospital visits and access to monitoring, but also an emotional and informational need, related to reassurance, autonomy and continuity of care during pregnancy. At the same time, the clinical feedback reinforced the importance of maintaining data quality, professional oversight and integration into healthcare workflows.
168 31 Inês Vasconcelos
169 31 Inês Vasconcelos
Therefore, the interviews validated the hybrid positioning of Obstech: a remote CTG monitoring solution that combines home-based accessibility, a patient-centered mobile application and a clinically robust platform for healthcare professionals.
170 31 Inês Vasconcelos
171 18 Marta Martins Filipe
h3. *3.3 Final Features and Specifications*
172 18 Marta Martins Filipe
173 18 Marta Martins Filipe
Based on the requirements gathering process and interview iterations, the final feature set for the Obstech prototype is defined as follows:
174 18 Marta Martins Filipe
175 1 Marta Martins Filipe
*Patient Interface (App)*:
176 26 Marta Martins Filipe
* Digital pregnancy booklet — unified view of all pregnancy information;
177 18 Marta Martins Filipe
* CTG session results displayed in plain language with visual summaries;
178 18 Marta Martins Filipe
* Gestational timeline showing week-by-week pregnancy progression;
179 18 Marta Martins Filipe
* Exam history and results archive;
180 18 Marta Martins Filipe
* Push notifications for alerts or messages from the clinical team;
181 18 Marta Martins Filipe
* Secure in-app messaging with the healthcare provider.
182 18 Marta Martins Filipe
183 18 Marta Martins Filipe
*Clinical Interface (Web Platform)*:
184 18 Marta Martins Filipe
* Multi-patient dashboard with real-time monitoring status;
185 18 Marta Martins Filipe
* Full CTG trace visualization (cardiotocogram viewer);
186 18 Marta Martins Filipe
* Structured clinical history per patient;
187 18 Marta Martins Filipe
* Automated report generation (exportable PDF);
188 18 Marta Martins Filipe
* Alert system for values outside clinical thresholds;
189 18 Marta Martins Filipe
* Trend analysis and comparison of CTG sessions over time;
190 18 Marta Martins Filipe
* Clinical decision support (pattern flagging, risk indicators).
191 18 Marta Martins Filipe
192 18 Marta Martins Filipe
h3. *3.4 Use Cases*
193 18 Marta Martins Filipe
194 34 Marta Martins Filipe
This section presents the use cases identified for the Obstech – Tele-CTG system. The use case diagram illustrates the interactions between the different system actors and the functionalities provided by the platform, offering a clear and structured view of the project's functional requirements.
195 18 Marta Martins Filipe
196 34 Marta Martins Filipe
h4. *3.4.1 System Actors*
197 30 Marta Martins Filipe
198 34 Marta Martins Filipe
The following actors were identified:
199 34 Marta Martins Filipe
200 34 Marta Martins Filipe
* Pregnant Woman — primary user of the mobile interface, who performs CTG monitoring at home, consults results and communicates with the clinical team.
201 34 Marta Martins Filipe
* Healthcare Professional — physician or nurse who monitors patients, analyses monitoring data, generates clinical reports, and manages notes and alerts.
202 34 Marta Martins Filipe
* Wearable Device — non-human actor responsible for acquiring CTG signals and transmitting them to the platform.
203 34 Marta Martins Filipe
* Obstech System / Platform — non-human actor that processes, validates and stores received data, and generates automatic alerts.
204 34 Marta Martins Filipe
* Administrator — responsible for user management, permissions, and integration with external hospital systems.
205 34 Marta Martins Filipe
206 34 Marta Martins Filipe
h4. *3.4.2 Use Case Diagram*
207 34 Marta Martins Filipe
208 40 Marta Martins Filipe
!Use_Cases-jpeg!
209 34 Marta Martins Filipe
Figure 1 – Use case diagram of the Obstech – Tele-CTG system
210 34 Marta Martins Filipe
211 34 Marta Martins Filipe
h4. *3.4.3 Detailed Use Case Descriptions*
212 34 Marta Martins Filipe
213 34 Marta Martins Filipe
The following tables describe each identified use case in detail, including the primary actor, pre-conditions, main flow of events, alternative flows, and post-conditions.
214 34 Marta Martins Filipe
215 34 Marta Martins Filipe
*UC01 - Log In*
216 34 Marta Martins Filipe
217 34 Marta Martins Filipe
!UC01.png!
218 34 Marta Martins Filipe
219 35 Marta Martins Filipe
*UC02 - Perform CTG Monitoring*
220 35 Marta Martins Filipe
221 35 Marta Martins Filipe
!UC02.png!
222 34 Marta Martins Filipe
223 18 Marta Martins Filipe
h3. *3.5 Activity Diagrams*
224 34 Marta Martins Filipe
225 18 Marta Martins Filipe
226 18 Marta Martins Filipe
227 18 Marta Martins Filipe
h2. *4. Design and Functionalities*
228 18 Marta Martins Filipe
229 18 Marta Martins Filipe
h3. *4.1 Mockup Building* - *+CONFIRMAR COM FIGMA + COLOCAR FOTOS!!!+*
230 18 Marta Martins Filipe
231 18 Marta Martins Filipe
Mockups were developed for both the patient-facing mobile application and the clinician-facing web platform. The design process followed a user-centered approach, with mockup iterations informed by the stakeholder interviews described in Section 3.2.
232 18 Marta Martins Filipe
233 18 Marta Martins Filipe
*Patient App — Key screens*:
234 18 Marta Martins Filipe
* Home screen / Dashboard: gestational week, next appointment, quick access to recent CTG result;
235 18 Marta Martins Filipe
* CTG Result screen: visual summary of last session with plain-language interpretation;
236 18 Marta Martins Filipe
* Pregnancy Booklet: timeline with all exams, results, and clinical notes;
237 18 Marta Martins Filipe
* Notifications: alerts and messages from the clinical team;
238 18 Marta Martins Filipe
* Profile & Settings: personal data, device pairing, language preferences.
239 18 Marta Martins Filipe
240 18 Marta Martins Filipe
*Clinical Platform — Key screens*:
241 18 Marta Martins Filipe
* Patient list dashboard: all monitored patients with status indicators;
242 18 Marta Martins Filipe
* Patient profile: full clinical history, gestational record, device status;
243 18 Marta Martins Filipe
* CTG viewer: interactive trace visualization with annotation tools;
244 18 Marta Martins Filipe
* Alerts panel: flagged events requiring clinical attention;
245 18 Marta Martins Filipe
* Reports: generation, preview, and export of clinical reports.
246 19 Marta Martins Filipe
247 19 Marta Martins Filipe
h3. *4.2 Device Integration* 
248 19 Marta Martins Filipe
249 19 Marta Martins Filipe
250 19 Marta Martins Filipe
251 19 Marta Martins Filipe
h3. *4.3 Data Consent* 
252 19 Marta Martins Filipe
253 19 Marta Martins Filipe
254 19 Marta Martins Filipe
h2. *5. Implementation*
255 19 Marta Martins Filipe
256 19 Marta Martins Filipe
The _Obstech_ prototype is implemented as a web and mobile application connected to a cloud-based backend. The implementation focuses on demonstrating the core user flows identified in the use cases, with emphasis on the patient and clinical interfaces.
257 19 Marta Martins Filipe
258 19 Marta Martins Filipe
*Planned technology stack:*
259 19 Marta Martins Filipe
+*ADICIONAR PONTOS!!*+
260 19 Marta Martins Filipe
261 19 Marta Martins Filipe
h2. *6. Project Management*
262 19 Marta Martins Filipe
263 19 Marta Martins Filipe
Project management for _Obstech – Tele-CTG_ is conducted using Redmine, the project management platform designated for this course. All tasks, milestones, and team assignments are tracked through Redmine issues and sprints.
264 19 Marta Martins Filipe
265 19 Marta Martins Filipe
*Project structure:*
266 19 Marta Martins Filipe
* Milestone 1 – State of the Art Review: literature review and competitive analysis;
267 19 Marta Martins Filipe
* Milestone 2 – Stakeholder Interviews: planning, conducting, and analyzing interviews;
268 19 Marta Martins Filipe
* Milestone 3 – Requirements & Use Cases: requirements specification and UML diagrams;
269 19 Marta Martins Filipe
* Milestone 4 – Mockup Design: wireframes and interactive mockups for both interfaces;
270 1 Marta Martins Filipe
* Milestone 5 – Prototype Implementation: technical development of the prototype;
271 27 Marta Martins Filipe
* Milestone 6 – Report & Presentation: final report writing and presentation preparation.
272 19 Marta Martins Filipe
273 19 Marta Martins Filipe
h2. *7. Problems/Difficulties*
274 19 Marta Martins Filipe
275 19 Marta Martins Filipe
276 19 Marta Martins Filipe
h2. *8. Conclusions*
277 19 Marta Martins Filipe
278 20 Marta Martins Filipe
The _Obstech – Tele-CTG_ project addresses a real and well-documented clinical gap: the absence of a home-based CTG monitoring solution that combines clinical-grade data quality, a meaningful patient experience, and seamless integration with the healthcare team.
279 19 Marta Martins Filipe
280 20 Marta Martins Filipe
The market assessment confirmed that existing solutions are polarized between high-precision hospital systems and accessible but clinically limited home devices. Obstech's hybrid model occupies a strategic position that bridges these two extremes, offering full CTG monitoring at home with a dual interface designed for both pregnant women and healthcare professionals.
281 20 Marta Martins Filipe
282 20 Marta Martins Filipe
283 19 Marta Martins Filipe
h2. *9. Future Work*
284 19 Marta Martins Filipe
285 19 Marta Martins Filipe
286 19 Marta Martins Filipe
h2. *10. Hyperlinks for App Mockup*
287 20 Marta Martins Filipe
288 20 Marta Martins Filipe
Interactive mockups for both the patient application and the clinical platform are available for review through the following links:
289 20 Marta Martins Filipe
290 28 Marta Martins Filipe
*Patient App Mockup (Figma):* https://www.figma.com/proto/znMYyLlW8g8Ft4tuAYhP5a/A-equipe-de-up202502464-team-library?node-id=3312-2&t=RihzMLqr8VuII7PF-1
291 29 Marta Martins Filipe
*Clinical Platform Mockup (Figma):* https://www.figma.com/proto/znMYyLlW8g8Ft4tuAYhP5a/A-equipe-de-up202502464-team-library?node-id=3410-1307&p=f&t=sKPc6qg4GZ0flH44-1&scaling=scale-down&content-scaling=fixed&page-id=3397%3A621&starting-point-node-id=3410%3A1307&show-proto-sidebar=1
292 20 Marta Martins Filipe
*Prototype Demo:* INSERIR LINK!!
293 20 Marta Martins Filipe
294 20 Marta Martins Filipe
h2. *11. Teaser*
295 20 Marta Martins Filipe
296 20 Marta Martins Filipe
_Obstech – Tele-CTG_ reimagines how pregnancy monitoring works. Instead of repeated hospital visits for routine CTG exams, pregnant women use a simple wearable device at home, and their clinical team gets the data instantly.
297 20 Marta Martins Filipe
298 20 Marta Martins Filipe
For the pregnant woman: a clear, reassuring app that shows her CTG results in plain language, tracks her pregnancy week by week, and keeps everything in one place: her digital pregnancy booklet.
299 20 Marta Martins Filipe
300 20 Marta Martins Filipe
For the healthcare team: a powerful clinical platform with full CTG traces, patient history, automated reports, and real-time alerts, everything needed to monitor patients remotely without compromising clinical quality.
301 20 Marta Martins Filipe
302 20 Marta Martins Filipe
_Obstech_ is the bridge between the hospital and the home.
303 20 Marta Martins Filipe
304 20 Marta Martins Filipe
305 20 Marta Martins Filipe
h2. *12. Presentation*
306 20 Marta Martins Filipe
307 20 Marta Martins Filipe
The final presentation of _Obstech – Tele-CTG_ will cover the following topics:
308 20 Marta Martins Filipe
+ADICIONAR PONTOS+
309 20 Marta Martins Filipe
310 20 Marta Martins Filipe
h2. *References*
311 20 Marta Martins Filipe
312 20 Marta Martins Filipe
The following scientific articles were reviewed as part of the state-of-the-art analysis: